New pages
Jump to navigation
Jump to search
- 00:40, 9 August 2024 Cerebral vascular resistance (hist | edit) [327 bytes] Fmichael1 (talk | contribs) (Created page with "Category:Neurophysiology")
- 00:40, 9 August 2024 Cerebral perfusion pressure (hist | edit) [327 bytes] Fmichael1 (talk | contribs) (Created page with "Category:Neurophysiology")
- 00:40, 9 August 2024 Cerebral blood flow (hist | edit) [327 bytes] Fmichael1 (talk | contribs) (Created page with "Category:Neurophysiology")
- 00:15, 9 August 2024 Cerebrospinal fluid (hist | edit) [714 bytes] Fmichael1 (talk | contribs) (Created page with "Category:Neurophysiology Category:Neurotrauma") Tag: Visual edit: Switched
- 06:08, 3 August 2024 Occipital artery (hist | edit) [2,365 bytes] Fmichael1 (talk | contribs) (Created page with "== Occipital Artery == The '''occipital artery''' arises from the external carotid artery (ECA) and supplies various structures in the head and neck region. === Origin and Course === The occipital artery originates from the posterior surface of the external carotid artery. It runs upward between the digastric muscle and the internal jugular vein, and it may course superficial or deep to the longissimus capitis muscle depending on the presence or absence of the occipit...")
- 05:59, 3 August 2024 Internal cerebral Vein (hist | edit) [61 bytes] Fmichael1 (talk | contribs) (Created page with "TODO")
- 05:27, 3 August 2024 Fetal PCA (hist | edit) [1,209 bytes] Fmichael1 (talk | contribs) (Created page with "thumb * Fetal PCA origin: common variant, seen in ~20-30% of pts * Posterior Communicating Artery (PCom) size > P1 seg of PCA, provides most of blood supply → known as “fetal PCom” * P1 seg can be hypoplastic or absent → influences stroke pattern, as PCA functions as part of anterior circulation * PCom, larger than P1, allows for collateral circulation * Fetal PCA positioning: superior or superolateral to oculomotor nerve; non-fetal PCA: PC...") Tag: Visual edit: Switched
- 05:13, 3 August 2024 Posterior Communicating Artery (hist | edit) [468 bytes] Fmichael1 (talk | contribs) (Created page with "= Infundibulum = thumb * Most commonly located in posterior communicating artery * Triangular shape, < 3mm, vessel origin at apex * Identified in 7-13% of normal arteriograms, can mimic saccular aneurysm * Though potential for bleed exists, rupture risk significantly ↓ compared to saccular intracranial aneurysm * Diagnostic features: conical shape, size, location <br clear="all"> Category:Neuroanatomy Category:Vascular anatomy") Tag: Visual edit: Switched
- 05:03, 3 August 2024 Maxillary Artery (hist | edit) [2,624 bytes] Fmichael1 (talk | contribs) (Created page with "* Arises as a terminal branch of the external carotid artery w/ the superficial temporal artery * passes through infratemporal fossa → (via pterygomaxillary fissure) pterygopalatine fossa. follow the maxillary nerve. = Segments = File:Maxillary Artery .png|thumb|Left lateral view. The maxillary artery is the larger of the two terminal branches of the external carotid artery. Its origin lies deep to the mandibular ramus (important landmark for locating the vessel). T...") Tag: Visual edit: Switched
- 04:44, 3 August 2024 Lesser Petrosal Nerve (hist | edit) [697 bytes] Fmichael1 (talk | contribs) (Created page with "thumb * Fnx - (General visceral efferent) stimulates saliva secretion from parotid gland * Origin - inferior salivatory nucleus of CN9, tympanic plexus, middle ear promontory * Course - Leaves middle ear through tiny canal in temporal bone, runs in middle cranial fossa on anterior surface of petrous bone * Skull exit - (exit point varies) foramen ovale, sphenopetrosal fissure, or Arnold’s canal * Gan...") Tag: Visual edit: Switched
- 04:36, 3 August 2024 Gasserian Ganglion (hist | edit) [875 bytes] Fmichael1 (talk | contribs) (Created page with "thumb * Gasserian ganglion, V1 form lateral limit of infratrochlear triangle. * Maxillary branch of trigeminal nerve exits GG center, runs to foramen rotundum. * Mandibular nerve occupies most of GG, enters the foramen ovale. * Mean length of MC: 6-16mm; GG: 15-25mm long, 4-5mm wide. * GG is sensory ganglion of trigeminal nerve, crescent shaped. * Subarachnoid space w/i MC extends ~4.9 mm medially and ~1.7 mm laterally beyond posterior edg...") Tag: Visual edit: Switched
- 04:33, 3 August 2024 Trigeminal Nerve (hist | edit) [146 bytes] Fmichael1 (talk | contribs) (Created page with "{{NoteBox|secondary}}<strong>Related pages</strong> * Gasserian Ganglion {{NoteBoxEnd}} Category:Neuroanatomy Category:Cranial nerves")
- 04:25, 3 August 2024 Vidian nerve (hist | edit) [2,161 bytes] Fmichael1 (talk | contribs) (Created page with "- Greater & deep petrosal nerves → vidian nerve; traverses vidian canal, unites w/ maxillary nerve & pterygopalatine ganglion in pterygopalatine fossa. - Vidian nerve sends branches to zygomatic nerve → anastomosis w/ lacrimal nerve to gland. - Pterygopalatine fossa: contains maxillary nerve branches, vidian nerve junction w/ pterygopalatine ganglion, & terminal branches of maxillary artery. - Vidian nerve enters posterior margin of sphenopalatine ganglion in pterygo...")
- 10:32, 26 July 2024 Deep brain stimulation (hist | edit) [127 bytes] Fmichael1 (talk | contribs) (Created page with "TODO")
- 10:31, 26 July 2024 DBS for Epilepsy (hist | edit) [520 bytes] Fmichael1 (talk | contribs) (Created page with "= SANTE TRIAL = ANT DBS for Epilepsy * First RCT - FDA approval in April 2018 * Sponsored by Medtronic * 157 patients enrolled, 110 implanted (2003-2007, 17 US centers) * Age 18-65 * Active 5V, cycling mode) vs. no stimulation during blinding (3 months) * 40.4% reduction in sz (active) vs. 14.5% reduction (control) (p=0.0017) * Side effects: paresthesia, memory decline, dizziness, implant site pain * Complications: infections (10/110) Category:Functional Neurosurgery...")
- 10:20, 26 July 2024 Vagus nerve stimulation (hist | edit) [571 bytes] Fmichael1 (talk | contribs) (Created page with "= Complications = * Voice change / hoarseness * Throat pain / pharyngitis * Dyspnea * Coughing * Parasthesias * Cardiac complications are rare * Infection * Hardware complications * Injury to the vagus nerve - permanent voice change = Outcomes = * 1 year - 35% median reduction of seizure frequency * 2 years - 43% * Long term - 72% ! * Response varies widely, some achieve seizure freedom, others have no benefit! * Improved alertness * Improved quality of life * Shorter s...") Tag: Visual edit: Switched
- 10:15, 26 July 2024 Epilepsy (hist | edit) [256 bytes] Fmichael1 (talk | contribs) (Created page with "{{NoteBox|secondary}}<strong>Related pages</strong> * Vagus nerve stimulation {{NoteBoxEnd}} Category:Functional Neurosurgery") Tag: Visual edit: Switched
- 18:59, 25 July 2024 Milan Consensus (hist | edit) [4,390 bytes] Fmichael1 (talk | contribs) (Created page with "== Milan Consensus Conference on Intracranial Pressure Monitoring in Traumatic Brain Injury == === Objective === The Milan Consensus Conference aimed to provide consensus on the practical applications of intracranial pressure (ICP) monitoring in severe adult traumatic brain injury (TBI) by discussing its indications and effectiveness. === Methods === A consensus conference was held on October 5, 2013, in Milan, bringing together neurosurgeons and intensivists with reco...")
- 07:55, 20 July 2024 Traumatic Brain Injury Biomarkers (hist | edit) [7,094 bytes] Fmichael1 (talk | contribs) (Created page with "=== Importance === Biomarkers for TBI are crucial for improving diagnosis, prognosis, treatment, and monitoring of brain injuries, ranging from mild concussions to severe coma. === Clinical Validation === Biomarkers such as Ubiquitin C-terminal hydrolase-L1 (UCH-L1) and Glial Fibrillary Acidic Protein (GFAP) have shown promise in diagnosing TBI. The Banyan BTI test, which measures these biomarkers, received FDA clearance in 2018. === Pathophysiology === Biomarkers refl...")
- 06:45, 20 July 2024 Traumatic Axonal Injury (hist | edit) [2,878 bytes] Fmichael1 (talk | contribs) (Created page with "== Traumatic Axonal Injury (TAI) Summary == === Definition and Mechanism === Traumatic axonal injury (TAI), previously known as diffuse axonal injury (DAI), occurs when shearing forces during acceleration or deceleration cause widespread microscopic axonal damage. This injury often results from rotational acceleration of the head, leading to shear, stretching, and compressive strains that deform brain tissue. TAI can occur without impact forces, although head impacts ty...")
- 06:14, 20 July 2024 CRASH-2 (hist | edit) [2,443 bytes] Fmichael1 (talk | contribs) (Created page with "== CRASH-2 Trial Summary == === Objective === The CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2) trial aimed to assess the effects of early administration of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage. === Methods === * '''Design:''' Multicenter, randomized, placebo-controlled trial. * '''Participants:''' 20,211 adult trauma patients with, or at risk of...") Tag: Visual edit: Switched
- 06:01, 20 July 2024 CRASH trial (hist | edit) [3,087 bytes] Fmichael1 (talk | contribs) (Created page with "== CRASH-1 Trial Summary == === Objective === The CRASH-1 (Corticosteroid Randomisation After Significant Head Injury) trial aimed to determine whether early administration of corticosteroids reduces death and disability in adults with head injury compared to placebo. === Methods === * '''Design:''' Randomised, placebo-controlled trial with centralised and non-centralised randomised concealed allocation. * '''Blinding:''' Clinicians, patients, and data analysts were bl...")
- 05:29, 20 July 2024 IMPACT Study (hist | edit) [2,666 bytes] Fmichael1 (talk | contribs) (Created page with "== IMPACT Study Summary == === Objective === The IMPACT (International Mission for Prognosis and Clinical Trial Design in Traumatic Brain Injury) study aimed to improve the prediction of outcomes in patients with traumatic brain injury (TBI) and to enhance clinical trial design for this population. === Methods === * '''Design:''' A comprehensive analysis based on individual patient data from 11 studies, including three observational studies and eight randomized control...")
- 04:49, 20 July 2024 BEST-TRIP (hist | edit) [3,591 bytes] Fmichael1 (talk | contribs) (Created page with "== BEST-TRIP Trial Summary == === Objective === The BEST-TRIP (Benchmark Evidence from South American Trials: Treatment of Intracranial Pressure) trial aimed to determine whether intracranial pressure (ICP) monitoring improves outcomes in patients with severe traumatic brain injury. === Methods === * '''Design:''' Multicenter, randomized controlled trial. * '''Participants:''' 324 patients aged 13 years or older with severe traumatic brain injury and treated in ICUs in...")
- 04:37, 20 July 2024 RESCUEicp (hist | edit) [2,265 bytes] Fmichael1 (talk | contribs) (Created page with "== RESCUEicp Trial Summary == === Objective === The RESCUEicp (Randomised Evaluation of Surgery with Craniectomy for Uncontrollable Elevation of Intracranial Pressure) trial aimed to assess the effectiveness of decompressive craniectomy in patients with traumatic brain injury and refractory intracranial hypertension. === Methods === * '''Design:''' Multicenter, randomized controlled trial. * '''Participants:''' 408 patients aged 10 to 65 years with traumatic brain inju...")
- 04:23, 20 July 2024 DECRA (hist | edit) [2,061 bytes] Fmichael1 (talk | contribs) (Created page with "== DECRA Trial Summary == === Objective === The DECRA (Decompressive Craniectomy in Diffuse Traumatic Brain Injury) trial aimed to evaluate whether decompressive craniectomy improves functional outcomes in patients with severe traumatic brain injury and refractory intracranial hypertension. === Methods === * '''Design:''' Multicenter, randomized controlled trial. * '''Participants:''' 155 adults with severe diffuse traumatic brain injury and intracranial hypertension r...") Tag: Visual edit: Switched
- 04:14, 20 July 2024 Traumatic Brain Injury (hist | edit) [4,439 bytes] Fmichael1 (talk | contribs) (Created page with " {{NoteBox|secondary}}<strong>Key articles</strong><hr> {| style="border-collapse: collapse; width: 100%;" |- | style="width: 15%; vertical-align: top;" | NASCIS I | style="width: 85%; vertical-align: top;" | Efficacy of high-dose vs. standard-dose steroids in acute SCI ⇒ <span style="background-color:#fff2cc;">no difference in neuro. recovery</span>; <span style="background-color:#ea9999;">high-dose steroids had ↑ early mortality & wound infx rates.</span> <i>(J...")
- 03:41, 20 July 2024 NASCIS III (hist | edit) [2,185 bytes] Fmichael1 (talk | contribs) (Created page with "== NASCIS III Trial Summary == === Objective === The NASCIS III (National Acute Spinal Cord Injury Study III) trial aimed to compare the efficacy of 24-hour and 48-hour administration of methylprednisolone, and 48-hour administration of tirilazad mesylate, in improving neurological recovery in patients with acute spinal cord injury. === Methods === * '''Design:''' Multicenter, double-blind, randomized controlled trial. * '''Participants:''' 499 patients with acute spin...")
- 03:30, 20 July 2024 NASCIS II (hist | edit) [1,914 bytes] Fmichael1 (talk | contribs) (Created page with "== NASCIS II Trial Summary == === Objective === The NASCIS II (National Acute Spinal Cord Injury Study II) trial aimed to evaluate the efficacy of high-dose methylprednisolone and naloxone in improving neurological recovery in patients with acute spinal cord injury. === Methods === * '''Design:''' Multicenter, double-blind, randomized controlled trial. * '''Participants:''' 487 patients with acute spinal cord injury were randomized to receive either high-dose methylpre...")
- 03:14, 20 July 2024 NASCIS I (hist | edit) [2,030 bytes] Fmichael1 (talk | contribs) (Created page with "== NASCIS I Trial Summary == === Objective === The NASCIS I (National Acute Spinal Cord Injury Study I) trial aimed to evaluate the efficacy of high-dose versus standard-dose methylprednisolone in improving neurological recovery in patients with acute spinal cord injury. === Methods === * '''Design:''' Multicenter, double-blind, randomized controlled trial. * '''Participants:''' 330 patients with acute spinal cord injury were randomized to receive either a high dose (1...") Tag: Visual edit: Switched
- 01:56, 20 July 2024 ARUBA trial (hist | edit) [2,479 bytes] Fmichael1 (talk | contribs) (Created page with "== ARUBA Trial Summary == === Objective === The ARUBA (A Randomized trial of Unruptured Brain Arteriovenous malformations) trial aimed to compare the risk of death and symptomatic stroke in patients with unruptured brain arteriovenous malformations (AVMs) managed with medical management alone versus medical management combined with interventional therapy (neurosurgery, embolization, or stereotactic radiotherapy). === Methods === * '''Design:''' Multicenter, non-blinded...")
- 23:19, 6 July 2024 כל מה שרציתם לדעת על הנשמה מלאכותית ופחדתם לשאול (hist | edit) [8,536 bytes] Fmichael1 (talk | contribs) (Created page with "<html dir="rtl"> בעוד שבמצב האופטימלי יאושפזו מטופלים מונשמים במסגרת יחידה ייעודית לטיפול נמרץ, נפוץ ביותר למצוא מטופלים מונשמים במחלקות אחרות ובפרט במסגרת ״טיפול מוגבר״ במחלקה פנימית וכירורגית. נושא הטיפול בחולה המונשם לרוב לא נלמד באופן ממצה במסגרת לימודי הרפוא...") Tag: Visual edit: Switched
- 10:29, 13 June 2024 Carpal Tunnel Syndrome (hist | edit) [246 bytes] Fmichael1 (talk | contribs) (Created page with "thumb * carful of injuring the recurrent branch of median nerve * at anaesthesias tourniquet w/ rubber tourniquet to empty blood * prof Kaye does under GA → local more painful") Tag: Visual edit
- 11:29, 22 May 2024 Colloid cysts (hist | edit) [1,032 bytes] Fmichael1 (talk | contribs) (Created page with "= Colloid Cyst Risk Score = +1 for + criteria # Age <65 # H/A # Axial diameter ≥7mm # Risk zones (zone 1 & 3) * ≥4 points = high risk for cyst progression and symptoms * 3 points = intermediate risk for cyst progression or symptoms * ≤2 points = low risk for cyst progression or symptoms == Anatomic risk zones for colloid cysts of the third ventricle == thumb The third ventricle was divided...") Tag: Visual edit
- 11:15, 22 May 2024 Arachnoid cysts (hist | edit) [2,049 bytes] Fmichael1 (talk | contribs) (Created page with "AKA leptomeningeal cysts, distinct from posttraumatic leptomeningeal cysts (AKA growing skull fractures), and unrelated to infection. Arachnoid cysts (AC) are congenital lesions that arise during development from splitting of arachnoid membrane (thus they are technically intra-arachnoid cysts) and contain fluid that is usually identical to CSF. They do not communicate with the ventricles or subarachnoid space. May be unloculated or may have septations. Typically lined...")
- 09:25, 22 May 2024 Malformations of Cortical Development (hist | edit) [3,253 bytes] Fmichael1 (talk | contribs) (Created page with "Categorized into three groups: {| class="wikitable" |- ! Group !! Characteristics !! Conditions |- | Group I || Malformations resulting from abnormal proliferation of neuronal and glial cells || Microcephaly, macrocephaly, FCDs without and with balloon cells (Taylor dysplasia types IIa and IIb), hemimegalencephaly, tuberous sclerosis, dysembryoplastic neuroepithelial tumors (DNETs), gangliogliomas, gangliocytomas |- | Group II || Malformations resulting from abnormal neu...")
